miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A).

scientific article published on July 2014

miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JCB.24665
P698PubMed publication ID24038379

P2093author name stringYan Li
Weina Li
Shouzhen Wu
Liqiang Song
Zhikui Li
P2860cites workEscape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2.Q36923079
Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinomaQ39432618
MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.Q39433284
miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.Q39459142
miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.Q39604058
Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cellsQ39690486
Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysisQ43108292
miR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3.Q45878289
The functions of animal microRNAsQ27860621
MicroRNAs: genomics, biogenesis, mechanism, and functionQ27861070
bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in DrosophilaQ28131827
Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistanceQ28267606
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cellsQ28278471
Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell linesQ28975767
MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTENQ29616575
Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells.Q33345021
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cellsQ33895297
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatinQ34094556
A miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistanceQ34110688
miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.Q34160439
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.Q34798833
miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humansQ35187051
Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC).Q35812082
Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice?Q36315282
MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemiaQ36437006
miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivoQ36610611
The roles of copper transporters in cisplatin resistanceQ36743623
P433issue7
P921main subjectnon-small-cell lung carcinomaQ3658562
P304page(s)1234-1242
P577publication date2014-07-01
P1433published inJournal of Cellular BiochemistryQ6294917
P1476titlemiR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A).
P478volume115

Reverse relations

cites work (P2860)
Q41439806A Role for The ATP7A Copper Transporter in Tumorigenesis and Cisplatin Resistance
Q38390451A three-microRNA signature predicts responses to platinum-based doublet chemotherapy in patients with lung adenocarcinoma.
Q36193907Downregulated miR-495 [Corrected] Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer
Q57024561Effect of microRNA-495 on lower extremity deep vein thrombosis through the TLR4 signaling pathway by regulation of IL1R1
Q26996766Epigenetics of lung cancer
Q33598360Expression, regulation and function of miR-495 in healthy and tumor tissues
Q64279220Genetic associations between the miRNA polymorphisms miR-130b (rs373001), miR-200b (rs7549819), and miR-495 (rs2281611) and colorectal cancer susceptibility
Q36790395MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
Q49449309MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.
Q49409530MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas.
Q38262308Molecular functions and significance of the MTA family in hormone-independent cancer
Q38343461Natural product modulators to overcome multidrug resistance in cancer.
Q26863490Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer
Q37366231Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer
Q60907638TAp73 regulates ATP7A: possible implications for ageing-related diseases
Q91710491The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Q55365074miR-495 inhibits proliferation, migration, and invasion and induces apoptosis via inhibiting PBX3 in melanoma cells.
Q38633144miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance
Q38667020microRNA and Lung Cancer.
Q26778918microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment

Search more.